A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

INTRODUCTION: Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated with high morbidity and mortality, especially in diffuse cutaneous SSc (dcSSc). Currently, there are several treatments available in early dcSSc that aim to change the disease course, including immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Spierings, Julia, van Rhenen, Anna, Welsing, Paco MW, Marijnissen, Anne CA, De Langhe, Ellen, Del Papa, Nicoletta, Dierickx, Daan, Gheorghe, Karina R, Henes, Joerg, Hesselstrand, Roger, Kerre, Tessa, Ljungman, Per, van de Loosdrecht, Arjan A, Marijt, Erik WAF, Mayer, Miro, Schmalzing, Marc, Schroers, Roland, Smith, Vanessa, Voll, Reinhard E, Vonk, Madelon C, Voskuyl, Alexandre E, de Vries-Bouwstra, Jeska K, Walker, Ulrich A, Wuttge, Dirk M, van Laar, Jacob M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978271/
https://www.ncbi.nlm.nih.gov/pubmed/33737437
http://dx.doi.org/10.1136/bmjopen-2020-044483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978271/
https://www.ncbi.nlm.nih.gov/pubmed/33737437
http://dx.doi.org/10.1136/bmjopen-2020-044483

Ejemplares similares